- Home
- CVRX vs HFRO Comparison
CVRX vs HFRO Comparison
Compare CVRX & HFRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVRX
- HFRO
- Stock Information
- Founded
- CVRX 2000
- HFRO 2000
- Country
- CVRX United States
- HFRO United States
- Employees
- CVRX N/A
- HFRO N/A
- Industry
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- HFRO Finance/Investors Services
- Sector
- CVRX Health Care
- HFRO Finance
- Exchange
- CVRX Nasdaq
- HFRO Nasdaq
- Market Cap
- CVRX 419.8M
- HFRO 377.4M
- IPO Year
- CVRX 2021
- HFRO N/A
- Fundamental
- Price
- CVRX $13.85
- HFRO $5.58
- Analyst Decision
- CVRX Strong Buy
- HFRO
- Analyst Count
- CVRX 7
- HFRO 0
- Target Price
- CVRX $17.83
- HFRO N/A
- AVG Volume (30 Days)
- CVRX 219.8K
- HFRO 421.7K
- Earning Date
- CVRX 02-04-2025
- HFRO 01-01-0001
- Dividend Yield
- CVRX N/A
- HFRO 12.00%
- EPS Growth
- CVRX N/A
- HFRO N/A
- EPS
- CVRX N/A
- HFRO 1.23
- Revenue
- CVRX $51,292,000.00
- HFRO $44,535,929.00
- Revenue This Year
- CVRX $27.21
- HFRO N/A
- Revenue Next Year
- CVRX $25.87
- HFRO N/A
- P/E Ratio
- CVRX N/A
- HFRO $5.50
- Revenue Growth
- CVRX 30.53
- HFRO N/A
- 52 Week Low
- CVRX $6.40
- HFRO $5.92
- 52 Week High
- CVRX $22.50
- HFRO $9.38
- Technical
- Relative Strength Index (RSI)
- CVRX 39.53
- HFRO 40.68
- Support Level
- CVRX $14.07
- HFRO $5.72
- Resistance Level
- CVRX $15.42
- HFRO $5.81
- Average True Range (ATR)
- CVRX 0.88
- HFRO 0.08
- MACD
- CVRX -0.23
- HFRO -0.02
- Stochastic Oscillator
- CVRX 13.84
- HFRO 15.39
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
About HFRO Highland Opportunities and Income Fund of Beneficial Interest
Highland Opportunities and Income Fund is a non-diversified, closed-end management investment company. Its investment objective is to Income Fund seeks growth of capital along with income. The company's portfolio of investments includes different industry investments such as Financial, Communication Services, Energy, Healthcare, Materials, and others.